Squarepoint’s TuHURA Biosciences HURA Stock Holding History

Squarepoint’s Portfolio HURA Stock Details HURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-12,506	Closed	-$40.4K	–	5193
2025 Q1	$40.4K	Sell	12,506 -42,029	-77%	-$155K	﹤0.01%	4375
2024 Q4	$223K	Buy	+54,535	New	+$290K	﹤0.01%	4386
2021 Q1	–	Sell	-7	Closed	-$15K	–	3703
2020 Q4	$15K	Buy	+7	New	+$17.6K	﹤0.01%	2843

Other funds holding HURA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AWM

Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return

SEM

Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return

Squarepoint's HURA Position: Q2 2025 in Review

Squarepoint sold out of TuHURA Biosciences (HURA) in Q2 2025, closing a stake of 12,506 shares — an estimated $40.4K sold.

Squarepoint first reported a position in HURA in Q4 2020 and held it in 3 quarters. The position peaked at $223K in Q4 2024. 50 funds tracked by Wall St. Rank hold HURA as of Q2 2025.

Squarepoint reported no remaining TuHURA Biosciences position as of Q2 2025 after selling out during the quarter.
Squarepoint sold 12,506 TuHURA Biosciences shares in Q2 2025, an estimated $40.4K.
Squarepoint first reported a position in TuHURA Biosciences in Q4 2020 and held it in 3 quarters.
Squarepoint's TuHURA Biosciences position peaked at $223K in Q4 2024.
50 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2025.

Based on Squarepoint's 13F filing for Q2 2025, filed 14 Aug 2025.